iconEarnings Announcement After Market Close

Gilead Sciences Inc GILD:NASDAQ

RT Quote | NASDAQ | USD
Last | 04/28/21 EDT
64.44quote price arrow down-0.23 (-0.36%)
Volume
7,753,191
52 week range
56.56 - 85.67

...

Loading . . .
  • Open64.69
  • Day High64.70
  • Day Low63.85
  • Prev Close64.44
  • 52 Week High85.67
  • 52 Week High Date04/30/20
  • 52 Week Low56.56
  • 52 Week Low Date12/31/20

Key Stats

  • Market Cap81.134B
  • Shares Out1.259B
  • 10 Day Average Volume6.29M
  • Dividend2.84
  • Dividend Yield4.41%
  • Beta0.41
  • YTD % Change10.61

KEY STATS

  • Open64.69
  • Day High64.70
  • Day Low63.85
  • Prev Close64.44
  • 52 Week High85.67
  • 52 Week High Date04/30/20
  • 52 Week Low56.56
  • 52 Week Low Date12/31/20
  • Market Cap81.134B
  • Shares Out1.259B
  • 10 Day Average Volume6.29M
  • Dividend2.84
  • Dividend Yield4.41%
  • Beta0.41
  • YTD % Change10.61

RATIOS/PROFITABILITY

  • EPS (TTM)0.06
  • P/E (TTM)1,130.53
  • Fwd P/E (NTM)8.96
  • EBITDA (MRQ)5.56B
  • ROE (MRQ)0.60%
  • Revenue (MRQ)24.689B
  • Gross Margin (MRQ)81.48%
  • Net Margin (MRQ)0.36%
  • Debt To Equity (MRQ)172.52%

EVENTS

  • Earnings Date04/29/2021
  • Ex Div Date03/12/2021
  • Div Amount0.71
  • Split Date-
  • Split Factor-

Profile

MORE
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. Its products for HIV/AIDS patients include Descovy...
Daniel O'Day
Chairman
Andrew Dickinson
Chief Financial Officer
Flavius Martin M.D.
Executive Vice President
Brett Pletcher
Executive Vice President
Address
333 LAKESIDE DR
Foster City, CA
94404
United States

Top Peers

SYMBOLLASTCHG%CHG
ZTS
Zoetis Inc
171.72+1.97+1.16%
AZN
AstraZeneca PLC
52.08-0.29-0.55%
GSK
GlaxoSmithKline PLC
37.70-0.03-0.08%
AMGN
Amgen Inc
236.71-18.42-7.22%
VRTX
Vertex Pharmaceuticals Inc
213.48-2.05-0.95%